Clinical Trial Update: Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial investigating ticagrelor's microcirculatory effects on tissue perfusion in peripheral arterial disease was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Peripheral Arterial Disease | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2021-07-07